Working Together to Find a Cure     Print Page | Close Window

Corporate Profile

Abeona Therapeutics is focused on developing and delivering gene therapy and plasma-based products for severe and life-threatening rare diseases. Developing therapies for rare disease requires new approaches and strong collaboration between researchers, industry, regulators and patient groups. Abeona was forged from the company’s close collaborations with key stakeholders all dedicated to transforming new biotechnology insights into breakthrough treatments for rare diseases such as Sanfilippo disorder, Batten disease, Fanconi anemia and other rare disorders.

Stock Chart

Stock chart for: ABEO.O.  Currently trading at $16.75 with a 52 week high of $17.90 and a 52 week low of $4.05.

Stock Quote

ABEO $16.75 + 0.25 (1.52%)
Exchange: NASDAQ CM
Today’s High: $17.05
Today’s Low: $16.11
52 Week High: $17.90
52 Week Low: $4.05
Today’s Volume: 1,107,925
As of September 19, 2017Refresh quote

Upcoming Events

Monday, September 25, 2017 through Wednesday, September 27, 2017
Cantor Fitzgerald's 3rd Annual Healthcare Conference
Wednesday, October 4, 2017 through Friday, October 6, 2017
Cell and Gene – Meeting on the Mesa
Wednesday, October 11, 2017
Abeona Therapeutics R & D Day
Thursday, October 12, 2017
Jefferies Gene Technology Investor Summit
Receive Email AlertsEmail Alert Icon
Sign up to receive email alerts whenever Abeona Therapeutics posts new information to the site. Just enter your email address and click Submit.
 
Data provided by Nasdaq. Minimum 15 minutes delayed.